Latest ophthalmic solution Stories
IRVINE, Calif., June 7, 2011 /PRNewswire/ -- Allergan, Inc. (NYSE: AGN), the maker of LATISSEÃ® (bimatoprost ophthalmic solution) 0.03%, announced today the launch of the 2011 LATISSEÃ® Wishes Challenge. Inspired by the tradition of blowing on an eyelash to make wishes come true, the campaign is gaining momentum for the second year by rallying women in support of the Make-A-Wish FoundationÃ®, a nonprofit organization dedicated to granting...
FDC has received approval from the FDA for its abbreviated new drug application, Ciprofloxacin ophthalmic solution. FDC's Ciprofloxacin Ophthalmic Solution is a broad spectrum antibiotic used for occular surface infections. The company has recently received approval for Timolol maleate ophthalmic solution. Another abbreviated new drug application Ofloxacin ophthalmic solution is in the final stages of approval.
- A social bee.